MedPath
NMPA Approval

Pregabalin Oral Solution

国药准字H20223098

March 1, 2022

Drug Information

普瑞巴林口服溶液

口服溶液剂

2%(200ml:4000mg)

化学药品

March 1, 2022

Company Information

Applicant Company

内江市经济技术开发区安吉街456号

Manufacturing Company

山东省德州市齐河县晏北街道办事处齐众大道127号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

普瑞巴林口服溶液 - NMPA 批准文号 | MedPath